Tony Godfrey
Concepts (323)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Reverse Transcriptase Polymerase Chain Reaction | 26 | 2000 | 243 |
Why?
| Lymph Nodes | 13 | 2001 | 106 |
Why?
| Esophageal Neoplasms | 16 | 2001 | 37 |
Why?
| Tumor Markers, Biological | 14 | 2001 | 112 |
Why?
| Adenocarcinoma | 14 | 1972 | 167 |
Why?
| Lymphatic Metastasis | 14 | 2001 | 77 |
Why?
| Lung Neoplasms | 11 | 1972 | 159 |
Why?
| Carcinoma, Non-Small-Cell Lung | 4 | 2004 | 23 |
Why?
| Head and Neck Neoplasms | 7 | 2004 | 47 |
Why?
| Gene Expression Regulation, Neoplastic | 11 | 1998 | 126 |
Why?
| Carcinoma, Squamous Cell | 8 | 1972 | 111 |
Why?
| RNA, Messenger | 13 | 2000 | 394 |
Why?
| Breast Neoplasms | 11 | 1972 | 185 |
Why?
| Polymerase Chain Reaction | 13 | 1997 | 279 |
Why?
| RNA, Neoplasm | 3 | 2004 | 41 |
Why?
| Melanoma | 7 | 1972 | 87 |
Why?
| Carcinoembryonic Antigen | 4 | 2001 | 8 |
Why?
| Neoplasms | 6 | 1971 | 239 |
Why?
| Neoplasm Proteins | 7 | 1998 | 110 |
Why?
| Prognosis | 15 | 1981 | 388 |
Why?
| Gene Expression Profiling | 4 | 2004 | 138 |
Why?
| Sentinel Lymph Node Biopsy | 3 | 2005 | 14 |
Why?
| Antigens, Neoplasm | 6 | 2004 | 56 |
Why?
| Humans | 61 | 1971 | 1856 |
Why?
| Cyclin-Dependent Kinase 6 | 1 | 2011 | 5 |
Why?
| Sensitivity and Specificity | 11 | 2000 | 427 |
Why?
| Genome, Human | 2 | 2006 | 29 |
Why?
| Cyclin-Dependent Kinase 4 | 1 | 2011 | 9 |
Why?
| Genes, Neoplasm | 2 | 2004 | 7 |
Why?
| Intraoperative Care | 1 | 2011 | 34 |
Why?
| Gene Amplification | 9 | 1998 | 22 |
Why?
| DNA, Neoplasm | 5 | 1999 | 75 |
Why?
| Cyclin D1 | 1 | 2008 | 22 |
Why?
| Reproducibility of Results | 9 | 2000 | 391 |
Why?
| Ovarian Neoplasms | 5 | 1973 | 64 |
Why?
| Neoplasm Staging | 8 | 2000 | 125 |
Why?
| Alternative Splicing | 2 | 2005 | 51 |
Why?
| Skin Neoplasms | 3 | 1976 | 97 |
Why?
| Female | 28 | 1971 | 1643 |
Why?
| Cell Adhesion Molecules | 4 | 2005 | 48 |
Why?
| Neoplastic Cells, Circulating | 1 | 2007 | 11 |
Why?
| Gene Expression | 4 | 2000 | 291 |
Why?
| Chromosomes, Human, Pair 11 | 3 | 2000 | 19 |
Why?
| DNA Mutational Analysis | 3 | 2000 | 110 |
Why?
| Mouth Neoplasms | 2 | 2002 | 20 |
Why?
| Alleles | 5 | 1997 | 108 |
Why?
| Thoracic Neoplasms | 1 | 2004 | 16 |
Why?
| Middle Aged | 15 | 1971 | 1161 |
Why?
| Male | 23 | 1971 | 1553 |
Why?
| Survival Analysis | 6 | 2000 | 205 |
Why?
| Patient-Centered Care | 1 | 2004 | 30 |
Why?
| Cisplatin | 1 | 2003 | 43 |
Why?
| Aged | 13 | 1971 | 988 |
Why?
| Neoplasm Recurrence, Local | 3 | 1981 | 118 |
Why?
| Delivery of Health Care | 1 | 2004 | 102 |
Why?
| Central Nervous System Diseases | 1 | 2002 | 33 |
Why?
| Monophenol Monooxygenase | 3 | 2002 | 8 |
Why?
| Immunohistochemistry | 8 | 2001 | 355 |
Why?
| Aged, 80 and over | 6 | 2005 | 599 |
Why?
| RNA | 1 | 2005 | 126 |
Why?
| Desmoglein 3 | 2 | 2006 | 2 |
Why?
| MicroRNAs | 2 | 2007 | 16 |
Why?
| DNA Primers | 6 | 1998 | 208 |
Why?
| Antineoplastic Agents | 2 | 1982 | 190 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2005 | 135 |
Why?
| Cadherins | 3 | 1997 | 32 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 1997 | 7 |
Why?
| Genes, Tumor Suppressor | 4 | 1997 | 37 |
Why?
| Chromosome Deletion | 1 | 1997 | 46 |
Why?
| MART-1 Antigen | 2 | 2004 | 2 |
Why?
| Mitomycins | 3 | 1972 | 13 |
Why?
| Adult | 10 | 1971 | 1317 |
Why?
| Chromosome Mapping | 4 | 1997 | 107 |
Why?
| Frozen Sections | 3 | 2002 | 16 |
Why?
| Barrett Esophagus | 3 | 2001 | 14 |
Why?
| Predictive Value of Tests | 3 | 2005 | 321 |
Why?
| Colorectal Neoplasms | 2 | 2006 | 55 |
Why?
| Base Sequence | 5 | 1998 | 371 |
Why?
| Radiation Tolerance | 1 | 1995 | 37 |
Why?
| Prostatic Neoplasms | 2 | 1997 | 120 |
Why?
| Keratin-20 | 2 | 2004 | 4 |
Why?
| Intermediate Filament Proteins | 2 | 2004 | 17 |
Why?
| Plasma | 2 | 2004 | 25 |
Why?
| Mutagenesis | 1 | 1995 | 74 |
Why?
| Receptors, Chemokine | 2 | 2004 | 24 |
Why?
| Ultraviolet Rays | 1 | 1995 | 76 |
Why?
| Microsatellite Repeats | 3 | 2000 | 24 |
Why?
| Exons | 4 | 1998 | 91 |
Why?
| Intraoperative Period | 2 | 2002 | 43 |
Why?
| Time Factors | 5 | 1971 | 896 |
Why?
| Kaplan-Meier Estimate | 2 | 2008 | 89 |
Why?
| Trans-Activators | 3 | 1998 | 113 |
Why?
| DNA Copy Number Variations | 1 | 2011 | 5 |
Why?
| Fibroblasts | 1 | 1995 | 179 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 2011 | 21 |
Why?
| Mutation | 5 | 2000 | 340 |
Why?
| Gene Knockdown Techniques | 1 | 2011 | 26 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2005 | 39 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2011 | 24 |
Why?
| Genes, erbB-2 | 1 | 2011 | 9 |
Why?
| Polymorphism, Restriction Fragment Length | 2 | 2000 | 32 |
Why?
| Pyridines | 1 | 2011 | 61 |
Why?
| ROC Curve | 1 | 2011 | 80 |
Why?
| Cell Line, Tumor | 2 | 2004 | 208 |
Why?
| Chromosome Aberrations | 3 | 1998 | 45 |
Why?
| Receptor, erbB-2 | 1 | 2011 | 25 |
Why?
| Piperazines | 1 | 2011 | 57 |
Why?
| Protein Kinase Inhibitors | 1 | 2011 | 59 |
Why?
| Neoplasm Invasiveness | 3 | 2000 | 105 |
Why?
| Prospective Studies | 2 | 2004 | 545 |
Why?
| Molecular Sequence Data | 4 | 1998 | 404 |
Why?
| Genotype | 2 | 2001 | 175 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2000 | 82 |
Why?
| Growth Differentiation Factor 15 | 1 | 2008 | 1 |
Why?
| Neural Cell Adhesion Molecule L1 | 1 | 2008 | 3 |
Why?
| Paired Box Transcription Factors | 1 | 2008 | 10 |
Why?
| N-Acetylgalactosaminyltransferases | 1 | 2008 | 4 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 15 |
Why?
| Genetic Markers | 3 | 2000 | 78 |
Why?
| Area Under Curve | 1 | 2008 | 47 |
Why?
| Protein Isoforms | 1 | 2008 | 86 |
Why?
| In Situ Hybridization, Fluorescence | 7 | 1998 | 53 |
Why?
| Genetic Variation | 1 | 2008 | 91 |
Why?
| Brain Neoplasms | 2 | 2001 | 116 |
Why?
| Precancerous Conditions | 1 | 2007 | 29 |
Why?
| Multivariate Analysis | 3 | 2001 | 225 |
Why?
| Cell Proliferation | 1 | 2011 | 227 |
Why?
| Synteny | 1 | 2006 | 3 |
Why?
| DNA Probes | 2 | 1998 | 61 |
Why?
| Disease-Free Survival | 2 | 2001 | 102 |
Why?
| Liver | 2 | 2000 | 248 |
Why?
| Colonic Neoplasms | 1 | 2007 | 63 |
Why?
| Antigens, CD | 1 | 2008 | 128 |
Why?
| Repressor Proteins | 1 | 2008 | 96 |
Why?
| Pulmonary Surfactant-Associated Protein B | 1 | 2006 | 5 |
Why?
| Trypsinogen | 1 | 2005 | 2 |
Why?
| Penetrance | 1 | 2005 | 3 |
Why?
| Neoplasm Metastasis | 3 | 1976 | 112 |
Why?
| Nucleic Acid Hybridization | 2 | 2000 | 94 |
Why?
| Survival Rate | 3 | 2001 | 250 |
Why?
| Autoanalysis | 1 | 2005 | 13 |
Why?
| Keratin-7 | 1 | 2005 | 5 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2005 | 17 |
Why?
| Keratins | 1 | 2005 | 27 |
Why?
| Animals | 7 | 1995 | 1031 |
Why?
| Fluorescence | 1 | 2005 | 46 |
Why?
| Thymus Gland | 1 | 2005 | 57 |
Why?
| T-Lymphocyte Subsets | 1 | 2005 | 70 |
Why?
| Microfilament Proteins | 1 | 2005 | 41 |
Why?
| Tumor Cells, Cultured | 6 | 1998 | 233 |
Why?
| Centrifugation | 1 | 2004 | 27 |
Why?
| Computational Biology | 1 | 2005 | 39 |
Why?
| Immunologic Memory | 1 | 2005 | 51 |
Why?
| Polymorphism, Single-Stranded Conformational | 2 | 2000 | 23 |
Why?
| Ribonucleases | 1 | 2004 | 42 |
Why?
| Paraffin Embedding | 2 | 1999 | 13 |
Why?
| Drug Resistance, Neoplasm | 1 | 2003 | 32 |
Why?
| Shock, Hemorrhagic | 1 | 2003 | 8 |
Why?
| Transcription, Genetic | 4 | 1998 | 253 |
Why?
| Heterozygote | 2 | 1998 | 80 |
Why?
| Metabolism | 1 | 2002 | 23 |
Why?
| Bone Marrow | 1 | 2004 | 109 |
Why?
| Nucleic Acids | 1 | 2002 | 10 |
Why?
| Nitric Oxide Synthase | 1 | 2003 | 44 |
Why?
| Temperature | 1 | 2002 | 137 |
Why?
| Carrier Proteins | 1 | 2005 | 177 |
Why?
| Amino Acid Sequence | 2 | 1998 | 319 |
Why?
| DNA Methylation | 3 | 1998 | 29 |
Why?
| Gene Dosage | 1 | 2000 | 24 |
Why?
| Glioblastoma | 1 | 2001 | 44 |
Why?
| Cell Transformation, Neoplastic | 1 | 2001 | 86 |
Why?
| Fragile X Syndrome | 1 | 2000 | 3 |
Why?
| Genome | 1 | 2000 | 30 |
Why?
| Receptor, Epidermal Growth Factor | 1 | 2001 | 54 |
Why?
| Mice | 4 | 2000 | 623 |
Why?
| Neuroblastoma | 1 | 2000 | 36 |
Why?
| Flow Cytometry | 3 | 2004 | 216 |
Why?
| Recurrence | 1 | 2001 | 261 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 1999 | 13 |
Why?
| Esophagectomy | 2 | 2007 | 14 |
Why?
| Oncogenes | 1 | 1999 | 24 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 1998 | 5 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 1998 | 14 |
Why?
| Up-Regulation | 3 | 2003 | 183 |
Why?
| Prostate | 1 | 2000 | 55 |
Why?
| RNA-Binding Proteins | 1 | 2000 | 55 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 67 |
Why?
| Cell Line | 3 | 1995 | 375 |
Why?
| Skin | 1 | 2000 | 177 |
Why?
| Gene Deletion | 1 | 1998 | 121 |
Why?
| Follow-Up Studies | 2 | 1981 | 553 |
Why?
| Nerve Tissue Proteins | 1 | 2000 | 128 |
Why?
| DNA | 2 | 1995 | 262 |
Why?
| Case-Control Studies | 2 | 2005 | 283 |
Why?
| Retrospective Studies | 3 | 1976 | 653 |
Why?
| Pyrimidine Dimers | 1 | 1995 | 5 |
Why?
| Cricetulus | 1 | 1995 | 39 |
Why?
| Receptors, CCR6 | 2 | 2004 | 1 |
Why?
| Receptors, CCR7 | 2 | 2004 | 3 |
Why?
| Cell Death | 1 | 1995 | 94 |
Why?
| DNA Damage | 1 | 1995 | 66 |
Why?
| Cricetinae | 1 | 1995 | 130 |
Why?
| DNA Repair | 1 | 1995 | 47 |
Why?
| Age Factors | 3 | 1976 | 480 |
Why?
| Cystadenocarcinoma | 1 | 1973 | 1 |
Why?
| Carmustine | 1 | 1973 | 25 |
Why?
| Hypercalcemia | 1 | 1971 | 17 |
Why?
| Antibiotics, Antineoplastic | 1 | 1971 | 35 |
Why?
| Tissue Array Analysis | 1 | 2011 | 27 |
Why?
| Loss of Heterozygosity | 2 | 2000 | 17 |
Why?
| Disease Progression | 2 | 2000 | 244 |
Why?
| In Situ Hybridization | 1 | 2011 | 135 |
Why?
| Proportional Hazards Models | 1 | 2011 | 123 |
Why?
| Cytotoxicity, Immunologic | 1 | 2009 | 54 |
Why?
| Immunoenzyme Techniques | 1 | 2009 | 125 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 2009 | 52 |
Why?
| Mitomycin | 1 | 1988 | 13 |
Why?
| RNA, Small Interfering | 1 | 2009 | 116 |
Why?
| Sampling Studies | 1 | 2007 | 40 |
Why?
| Microarray Analysis | 1 | 2007 | 24 |
Why?
| Cluster Analysis | 1 | 2007 | 66 |
Why?
| Peptide Fragments | 1 | 2009 | 144 |
Why?
| Cohort Studies | 1 | 2011 | 332 |
Why?
| Interferon-gamma | 1 | 2009 | 133 |
Why?
| Blotting, Western | 1 | 2009 | 275 |
Why?
| Pancreatitis | 1 | 2005 | 24 |
Why?
| Trypsin | 1 | 2005 | 63 |
Why?
| Monitoring, Immunologic | 1 | 2005 | 3 |
Why?
| Leukocytes | 2 | 1973 | 94 |
Why?
| Antigens, CD95 | 1 | 2005 | 16 |
Why?
| Hepatocyte Growth Factor | 1 | 2005 | 14 |
Why?
| Necrosis | 1 | 2005 | 82 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2005 | 34 |
Why?
| DNA, Complementary | 1 | 2005 | 139 |
Why?
| Pancreas | 1 | 2005 | 46 |
Why?
| Cyclooxygenase 2 Inhibitors | 1 | 2005 | 45 |
Why?
| Tissue Distribution | 1 | 2005 | 124 |
Why?
| Remission, Spontaneous | 2 | 1972 | 32 |
Why?
| Proteomics | 1 | 2005 | 36 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2005 | 47 |
Why?
| Chemotaxis | 1 | 2004 | 20 |
Why?
| Internet | 1 | 2005 | 64 |
Why?
| Polymorphism, Genetic | 1 | 2005 | 94 |
Why?
| Down-Regulation | 1 | 2005 | 150 |
Why?
| Microscopy, Immunoelectron | 1 | 2003 | 22 |
Why?
| Peroxisomes | 1 | 2003 | 4 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2005 | 91 |
Why?
| Genetic Predisposition to Disease | 1 | 2005 | 131 |
Why?
| Catalase | 1 | 2003 | 27 |
Why?
| Cyclooxygenase 2 | 1 | 2005 | 77 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2003 | 39 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 66 |
Why?
| Cell Movement | 1 | 2005 | 163 |
Why?
| Proto-Oncogenes | 1 | 2002 | 25 |
Why?
| Hepatocytes | 1 | 2003 | 42 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2005 | 113 |
Why?
| Cytosol | 1 | 2003 | 79 |
Why?
| Biological Markers | 1 | 2005 | 262 |
Why?
| Forecasting | 1 | 2002 | 147 |
Why?
| Vasopressins | 1 | 1982 | 21 |
Why?
| Microscopy, Confocal | 1 | 2003 | 105 |
Why?
| Biopsy | 1 | 2003 | 207 |
Why?
| Protein Binding | 1 | 2005 | 256 |
Why?
| Phosphorylation | 1 | 2005 | 224 |
Why?
| Fluorouracil | 1 | 1981 | 49 |
Why?
| Leukemia, Radiation-Induced | 1 | 2000 | 5 |
Why?
| Sequence Analysis, DNA | 1 | 2001 | 110 |
Why?
| Nucleic Acid Amplification Techniques | 1 | 2000 | 10 |
Why?
| Clinical Trials as Topic | 1 | 2005 | 251 |
Why?
| Esophagus | 1 | 2001 | 49 |
Why?
| Genes, p53 | 1 | 2001 | 43 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2000 | 8 |
Why?
| Chromosomes, Human, Pair 22 | 1 | 2000 | 12 |
Why?
| Nausea | 1 | 1982 | 34 |
Why?
| Color | 1 | 2000 | 23 |
Why?
| Genes, myc | 1 | 2000 | 22 |
Why?
| Fragile X Mental Retardation Protein | 1 | 2000 | 1 |
Why?
| Chromosomes | 1 | 2000 | 32 |
Why?
| Membrane Proteins | 1 | 2005 | 233 |
Why?
| Mice, Inbred Strains | 1 | 2000 | 118 |
Why?
| Genetic Testing | 1 | 2000 | 49 |
Why?
| Leukemia, Myeloid | 1 | 2000 | 37 |
Why?
| Rats, Sprague-Dawley | 1 | 2003 | 257 |
Why?
| Trinucleotide Repeat Expansion | 1 | 2000 | 21 |
Why?
| Chromones | 1 | 1999 | 22 |
Why?
| Fluorescent Dyes | 1 | 2000 | 115 |
Why?
| Morpholines | 1 | 1999 | 28 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1998 | 4 |
Why?
| Chromosome Disorders | 1 | 1998 | 17 |
Why?
| Zinc Fingers | 1 | 1998 | 20 |
Why?
| Mice, Inbred BALB C | 1 | 2000 | 176 |
Why?
| Karyotyping | 1 | 1998 | 47 |
Why?
| Cell Division | 1 | 2001 | 273 |
Why?
| Introns | 1 | 1998 | 58 |
Why?
| Sex Factors | 1 | 2000 | 284 |
Why?
| Mice, Transgenic | 1 | 2000 | 209 |
Why?
| Mice, Knockout | 1 | 2000 | 265 |
Why?
| Cloning, Molecular | 1 | 1998 | 183 |
Why?
| Enzyme Inhibitors | 1 | 1999 | 216 |
Why?
| Injections, Intravenous | 1 | 1976 | 105 |
Why?
| Promoter Regions, Genetic | 1 | 1998 | 188 |
Why?
| Mice, Inbred C57BL | 1 | 2000 | 318 |
Why?
| Rats | 1 | 2003 | 530 |
Why?
| Bone Neoplasms | 1 | 1976 | 83 |
Why?
| Postoperative Care | 1 | 1973 | 84 |
Why?
| Drug Resistance | 1 | 1973 | 83 |
Why?
| Gastrointestinal Neoplasms | 1 | 1972 | 20 |
Why?
| Dose-Response Relationship, Drug | 1 | 1976 | 431 |
Why?
| Plicamycin | 1 | 1971 | 2 |
Why?
| Sarcoma | 1 | 1972 | 42 |
Why?
| Evaluation Studies as Topic | 1 | 1972 | 178 |
Why?
| Testicular Neoplasms | 1 | 1972 | 26 |
Why?
| Lymphoma | 1 | 1972 | 96 |
Why?
| Blood Platelets | 1 | 1973 | 67 |
Why?
| Adolescent | 1 | 1971 | 891 |
Why?
| Osmolar Concentration | 1 | 1982 | 91 |
Why?
| Mastectomy | 1 | 1981 | 26 |
Why?
| Menopause | 1 | 1981 | 27 |
Why?
| Methotrexate | 1 | 1981 | 40 |
Why?
| Random Allocation | 1 | 1981 | 160 |
Why?
| Cyclophosphamide | 1 | 1981 | 82 |
Why?
| Drug Therapy, Combination | 1 | 1981 | 189 |
Why?
| Blood Pressure | 1 | 1982 | 205 |
Why?
|
|
Godfrey's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
